Nabota 200U
Invest in more volume to cover larger treatment areas with Nabota. It is developed by Daewoong Pharmaceutical Co. in South Korea and uses only highly purified botulinum toxin for muscle relaxation, resulting in fewer wrinkles and facial lines.
Nabota is available in 1 × 200U per vial in each package.
- Packaging
- 1 × 200U vial
- Duration of effect
- 4–6 months
- Storage
- 2–8 °C, refrigerated
- Shelf life
- 36 months from the manufacturing date
About Nabota 200U
Nabota 200U has twice the capacity of Nabota 100U and delivers the same ultra-pure, FDA-approved neurotoxin in a bigger dose size, making it perfect for advanced aesthetic practitioners. This variant is commonly used for full-face neuromodulation, treatment of masseter hypertrophy, trapezius slimming and body Botox regimens. Because Nabota maintains potency across dilution ranges, doctors can administer large-area injections efficiently and safely.
Daewoong Pharma created Nabota using cutting-edge technology, leveraging its 30-year bio-product experience and proprietary manufacturing techniques. As a result, Nabota 200U, introduced in 2015, contains the purest botulinum toxin type A. Following the revolutionary Nabota 100U, Daewoong expanded the dosing possibilities by introducing the 50U and 200U versions in the same year, to make it easier for both doctors and patients.
Nabota 200U is a high-purity product manufactured using Daewoong’s exclusive purification technology. This ensures that Nabota is both safe and effective as a Botox alternative. Furthermore, Nabota 200U demonstrates rapid improvement in the eradication of glabellar lines after a few weeks of treatment, with the initial effects appearing two days after injection. Patients are delighted after completing treatment sessions with Nabota, displaying superior results when compared to other brands. Patients do not develop tolerance to Nabota after four months of treatment, even when given low doses of 20 units. Overall, Nabota 200U significantly improves skin by reducing aging-related concerns such as deep frown lines and eye wrinkles (crow’s feet), and by facial contouring.
Key features of Nabota 200U
- 01A larger-capacity formulation especially designed for multiple use in clinics and by doctors.
- 02Offers excellent stability after dilution.
- 03Corrects deep wrinkles in the facial area, which include glabellar lines and nasolabial folds.
- 04Nabota is approved by the US FDA, as Jeuveau, for its safety and performance.
- 05A highly purified product manufactured with an innovative purification process, from which impurities are completely removed to guarantee a safe injection into the body.
- 06Improves hyperhidrosis, particularly on the palms and soles of the feet.
- 07Treats blepharospasm, which is the involuntary blinking or twitching of the eyelids.
- 08Improves wrinkles surrounding the periorbital and perioral areas.
- 09Because of its quality and excellence, Nabota has secured contracts to export its final products to over 90 countries globally.
Product formulation
- 200U of Clostridium botulinum toxin type A
- 0.5 mg human serum albumin, acting as a stabilizer
- 0.9 mg sodium chloride, as a tonicity adjuster
Application sites
- Jawline slimming
- Shoulder (trapezius) contouring
- Neck rejuvenation
- Calf reduction
- Full-face wrinkle management
- Glabellar frown lines
- Hyperhidrosis in the palms, thighs and armpits
Duration of effect
4–6months
In most cases, the initial effect occurs 1 to 3 days following the treatment session with Nabota, with the complete results peaking one to two weeks later. Results last for at least 4 months and at most 6 months.
Product specifications of Nabota 200U
Nabota 200U must be used only by medical professionals, to prevent untoward adverse reactions and achieve optimal results. Nabota reconstitution and dilution chart
- Packaging
- 1 × 200U vial
- Composition
- 200U Clostridium botulinum toxin type A, 0.5 mg human serum albumin, 0.9 mg sodium chloride
- Cannula size
- 27G–30G
- Injection depth
- Intramuscular
- Treatment areas
- Eyelids (blepharospasm), glabella/frown lines, calf muscles, forehead, palms and soles of the feet
- Recommended dosage
- Using a sterile 30G needle, administer 0.1 mL to each of the five injection sites, two in each corrugator muscle and one in the procerus muscle, for a total dose of 20 units for treating prominent glabellar lines with Nabota 200U.
- Treatment interval
- Maintenance treatment sessions no sooner than 3 months after the initial procedure. Avoid frequent treatment sessions, to prevent tolerance to the product and overdosage.
- Duration of effect
- 4–6 months
- Storage
- Store at 2–8 °C, refrigerated, in its hermetic container
- Shelf life
- 36 months from the manufacturing date
- Manufacturer
- Daewoong Pharmaceutical Co., Ltd.
Order Nabota through Nabota USA
Request pricing or send a purchasing inquiry for Nabota 200U, or ask about availability, specifications and professional-use information.